您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Chinese diabetes Market Report

健康网讯：

Research Report on Chinese diabetes Market

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006 
Format:  Hardcopy and Adobe PDF 
Price:  US$2,400 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
http://www.healthoo.com

Table of contents

Abstract
Foreword
1 Epidemiology of diabetes in China
  1.1 Trend of Epidemiology and current status
  1.2 Examples of Epidemiology investigation
  1.3 Etiological factors in China
2 Categories and action mechanisms of antidiabetic drugs
  2.1 Categories
  2.2 Action mechanisms
  2.3 Marketed breeds in China
  2.4 Breeds adopted in catalogue of Drugs for Basic National Medical I
nsurance
3 Market analysis of antidiabetic drugs
  3.1 Market scale and category share
  3.2 Leading breeds last year last year
  3.3 Leading enterprises last year
  3.4 Market analysis of sulfonylurea class
    3.4.1 Glipizide
    3.4.2 Gliquidone
    3.4.3 Gliclazide
    3.4.4 Glimepiride
    3.4.5 Glibenclamide
    3.4.6 Tolbutamide
  3.5 Market analysis of biguanides class
    3.5.1 sales value
    3.5.2 Breakdown of Metformin
  3.6 α-glucosidase inhibitor
       3.6.1 Acarbose
       3.6.2 Voglibose
  3.7 Insulin sensitizer
  3.8 Insulin secretagogues
      3.8.1 Repaglinide
      3.8.2 Nateglinide
  3.9 Insulin class
  3.10 Prepared Chinese Medicine
  3.11 General trend of oral antidiabetic drugs
4 Research and development in China
  4.1 List of Domestic marketd products and import procucts
  4.2 Status of application and approval